BioTrack Capital
58
37M
45
7.25
4
0.22
- Areas of investment
Summary
BioTrack Capital is the famous VC, which was founded in 2016. The venture was found in Asia in China. The main department of described VC is located in the Shanghai.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the BioTrack Capital, startups are often financed by Vision Plus Capital, Morningside Venture Capital, CASH Capital. The meaningful sponsors for the fund in investment in the same round are CASH Capital, Fosun Group, China Creation Ventures (CCV). In the next rounds fund is usually obtained by China Creation Ventures (CCV), CASH Capital, ZWC Partners.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biopharma, Wellness. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular portfolio startups of the fund, we may highlight Haihe Biopharma, HC Scientific.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2019.
Investments analytics
Analytics
- Total investments
- 58
- Lead investments
- 4
- Rounds per year
- 7.25
- Follow on index
- 0.22
- Investments by industry
- Health Care (31)
- Biotechnology (30)
- Medical (20)
- Medical Device (12)
- Pharmaceutical (9) Show 26 more
- Investments by region
-
- China (50)
- United States (5)
- Singapore (1)
- Peak activity year
- 2021
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 72M
- Group Appearance index
- 0.98
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Bioyond Tech | 03 Apr 2023 | Artificial Intelligence, Robotics, Medical Device | Early Stage Venture | 30M | Shandong, Pudong, China |
| Shenluo Medical | 18 Apr 2024 | Early Stage Venture | Hangzhou, Zhejiang, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.